Tilray | TRLY - Dochód Netto

Cena Akcji
8.54
Dzienna Zmiana
-0.58 -6.36%
Miesięcznie
-17.57%
Rocznie
818.28%
Q1 Prognozy TE
8.33




Dochód Netto Zmiana Data
Acasti Pharma USD -938K 2.42M 2025-09
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Cronos Group USD -1.82M 24.14M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Moderna USD -200M 625M 2025-09
Organigram Holdings CAD 19.97M 57.93M 2025-12
Organon & Co USD 160M 15M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Tectonic Therapeutic USD -19.23M 186K 2025-12
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zealand Pharma A/S -379.12M 25.12M 2025-12